Joseph Erhardt, VP, Oncology Discovery & Scientific Partnership, Janssen Research & Development, LLC, Spring House, PA, USA, Tel: +1-215-272-5220 Janssen Research & Development, LLC, one of the ...
JNJ-2056 is under clinical development by Johnson & Johnson Innovative Medicine and currently in Phase II for Alzheimer's Disease.
Janssen, a subsidiary of J& ... "This is a historic moment in oncology. We are truly honored to have received this Breakthrough Designation and are pleased for patients and clinicians with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback